16513-1-AP

antibody from Proteintech Group

Targeting: CXXC5 HSPC195, RINF, WID

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

16513-1-AP

Provider

Proteintech Group

Product name

CXXC5 antibody

Antibody type

Polyclonal

Description

KD/KO validated CXXC5 antibody (Cat. #16513-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB, ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway.

Wang W, Zhang Z, Zhao M, Wang Y, Ge Y, Shan L
The Journal of biological chemistry 2023 Jan;299(1):102812

---

Role of Wnt/β-catenin signaling pathway in ameloblast differentiation in relevance to dental fluorosis.

Zou T, Ma L, Gu L, Xi S, Zhang K, Guo X
Chemico-biological interactions 2022 Nov 1;367:110145

---

The epigenetic regulator RINF (CXXC5) maintains SMAD7 expression in human immature erythroid cells and sustains red blood cells expansion.

Astori A, Matherat G, Munoz I, Gautier EF, Surdez D, Zermati Y, Verdier F, Zaidi S, Feuillet V, Kadi A, Lauret E, Delattre O, Lefèvre C, Fontenay M, Ségal-Bendirdjian E, Dusanter-Fourt I, Bouscary D, Hermine O, Mayeux P, Pendino F
Haematologica 2022 Jan 1;107(1):268-283

---

Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation.

Wu X, Dong W, Kong M, Ren H, Wang J, Shang L, Zhu Z, Zhu W, Shi X
Frontiers in cell and developmental biology 2021;9:680344

---

A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.

He Y, Wei T, Ye Z, Orme JJ, Lin D, Sheng H, Fazli L, Jeffrey Karnes R, Jimenez R, Wang L, Wang L, Gleave ME, Wang Y, Shi L, Huang H
Nature communications 2021 Mar 9;12(1):1521

---

NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.

Tan S, Li H, Zhang W, Shao Y, Liu Y, Guan H, Wu J, Kang Y, Zhao J, Yu Q, Gu Y, Ding K, Zhang M, Qian W, Zhu Y, Cai H, Chen C, Lobie PE, Zhao X, Sun J, Zhu T
Oncogene 2018 Aug;37(35):4887-4900

---

Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs.

Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, Zhou C, Fang Y, Liu J, Yang J, Chen X, Li T, Zang A, Yin S, Li B, Plumas J, Chaperot L, Zhang X, Xu G, Jiang L, Shen N, Xiong S, Gao X, Zhang Y, Xiao H
The Journal of experimental medicine 2017 May 1;214(5):1471-1491

---

KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors.

Cui Z, Shen Y, Chen KH, Mittal SK, Yang JY, Zhang G
Scientific reports 2017 Jan 9;7:40325

---

CXXC5 is required for cardiac looping relating to TGFβ signaling pathway in zebrafish.

Peng X, Li G, Wang Y, Zhuang J, Luo R, Chen J, Chen F, Shi Y, Li J, Zhou Z, Mo X, Liu X, Yuan W, Zeng Q, Li Y, Jiang Z, Wan Y, Ye X, Xu W, Wang X, Fan X, Zhu P, Wu X, Deng Y
International journal of cardiology 2016 Jul 1;214:246-53